Adverse Associations Between Maternal Deoxynivalenol Exposure and Birth Outcomes: a Prospective Cohort Study in China.
Tan, Tianqi,Chen, Tingting,Zhu, Wenwen,Gong, Lin,Yan, Yizhong,Li, Qian,Chen, Li,Li, Yiling,Liu, Jialin,Li, Yanan,Yang, Xuefeng,Hao, Liping,Wang, Huaiji,Yang, Nianhong,Wei, Sheng
DOI: https://doi.org/10.1186/s12916-023-03011-5
IF: 9.3
2023-01-01
BMC Medicine
Abstract:Deoxynivalenol (DON), one of the most prevalent mycotoxins, has been found to cause fetal growth retardation in animals. However, limited evidence exists regarding its effects on pregnant women. Maternal urinary concentration of total DON (tDON) and free DON (fDON) in the second trimester was measured using liquid chromatography with tandem mass spectrometry. Provisional daily intake (PDI) of DON was calculated based on tDON concentration. Linear and logistic regression models were used to evaluate the association between DON exposure levels and birth weight, birth length, and the risk of small for gestational age (SGA). Among 1538 subjects, the median concentrations of tDON and fDON were 12.1 ng/mL and 5.1 ng/mL, respectively. The PDI values revealed that the median DON intake was 0.7 µg/kg bw, and 35.9